http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5540925-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9089461ee71353d9df911820ff129558
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1703
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-463
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
filingDate 1994-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28a3dd4abdd61b47eac9be5d57ab0b42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8509b93457a0372a3043f1b93f4d77a
publicationDate 1996-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5540925-A
titleOfInvention Compositions comprising ONCONASE (TM) and STELAZINE (TM) or TAMOXIFEN (TM)
abstract A pharmaceutical to be sold under the ONCONASE trademark, as described in pending commonly owned application application Ser. No. 07/436,141 filed Nov. 13, 1989 is combined with other drugs sold under the trademarks TAMOXIFEN and STELAZINE. The combination of ONCONASE with TAMOXIFEN has unexpected bioactivity in vitro against ASPC-1 human pancreatic adenocarcinoma cells and the combination of ONCONASE with STELAZINE has unexpected bioactivity in vitro against A-549 human lung carcinoma cells.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6630453-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11624095-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6916791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5728805-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110279722-A
priorityDate 1988-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4882421-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4195017-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4888172-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6305
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7018
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7405
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10436
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398727
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128792454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135728745
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2733526
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID352546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226449248
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129137297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57422521
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53686073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3032583
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128814347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129892662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396147
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234162033
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423730

Total number of triples: 55.